P

PTC Therapeutics

PTCT

32.710
USD
-1.19
(-3.51%)
Market Open
Volume
8,092
EPS
0
Div Yield
0
P/E
-6
Market Cap
3,055,812,653
Related Instruments
A
ADAP
-0.05000
(-3.79%)
1.27000 USD
B
BLUE
-0.06000
(-5.26%)
1.08000 USD
C
CRSP
-2.450
(-4.28%)
54.840 USD
E
EDIT
-0.28500
(-5.26%)
5.13500 USD
F
FATE
-0.46000
(-8.61%)
4.88000 USD
N
NTLA
-1.100
(-4.19%)
25.130 USD
R
RARE
-0.870
(-1.93%)
44.140 USD
S
SGMO
-0.09690
(-12.11%)
0.70340 USD
S
SRPT
1.650
(1.16%)
144.000 USD
X
XLRN
0
(0%)
0.000000 USD
News

Title: PTC Therapeutics

Sector: Healthcare
Industry: Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.